Portola Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (29)

Latest Posts

About This Stock More About This Stock
Biotech M&A Deal Looks Too Rich For Its Blood
Article By: Lipper Alpha Insight
Wednesday, May 6, 2020 10:46 AM EDT
Alexion Pharmaceuticals (ALXN) is either buying Portola Pharmaceuticals (PTLA) on the cheap at $1.4 billion, or paying a whopping premium – it all depends on your starting date.
In this article: ALXN, PTLA
Read
Wall Street's Top Stories For Monday, Dec 31
Article By: The Fly
Monday, December 31, 2018 5:12 PM EDT
Though December has been a bad month for the market, stocks opened in positive territory on the prospects of progress in the trade negotiations between the U.S. and China. Plus company news updates on Amazon, Disney, Verizon, and more.
In this article: CWH, DIS, VZ, AMZN, HRTX, PTLA, APHA
Read
Abbvie Earnings Drive Biotech Stocks Higher With Large Caps Dominant
Article By: Rod Raynovich
Friday, January 26, 2018 6:44 PM EDT
Biotech stocks soared again today to new highs driven by Abbvie Inc. earnings and overall sector strength. Momentum was strong in the general market with NASDAQ up 1.28% and the S&P up 1.18%. The M&A theme should be the driver in 2017.
In this article: IBB, REGN, BIIB, NBIX, XBI, ICPT, ESPR, ABBV, PTLA
Read
Citi Still Expects FDA Approval For Portola Despite 90 Day Delay
Article By: The Fly
Thursday, December 28, 2017 7:39 AM EDT
After speaking to management, Citi analyst Yigal Nochomovitz expects Portola Pharmaceuticals' AndexXa to be approved on or before the new FDA action date of May 4, 2018.
In this article: PTLA
Read
Update On Currently Recommended Stocks
Article By: SmithOnStocks
Monday, September 25, 2017 4:19 PM EDT
In this report I update my objectives and include several buy recommendations in the biotech sphere.
In this article: CYTK, AIS, NWBO, PTLA, RGEN, CYRX, BMY, ALIM, AGEN, EYPT, AMAG, WINT, AMGN, GNE, BIIB
Read

PARTNER HEADLINES

Latest Tweets for $PTLA

No tweets yet!